Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02645617 · ClinicalTrials.gov registry record · Phase 1

Safety Evaluation of Advantage Anti-Caries Varnish

A Phase 1 study of Dental Caries, sponsored by Advantage Dental Services.

Completed
Registry status
Phase 1
Development phase
12
Enrollment target
1
Study location

NCT02645617 is a Phase 1 study of Dental Caries that has completed, run by Advantage Dental Services. The registered enrollment target is 12 participants, below the 722-participant average among 30 other Dental Caries trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02645617, a Phase 1 study of Dental Caries, has completed, sponsored by Advantage Dental Services.

COMPLETED
Registry status
Phase 1
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.

Conditions Studied

Interventions

  • DRUG Varnish

Study Locations (1)

Washington

  • University of Washington Regional Clinical Dental Research Center - Seattle

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2016-03-30
Est. Completion 2016-10-20
Phase Phase 1

Sponsor

Advantage Dental Services

2 total trials

What the Registry Record Tells You About NCT02645617

The ClinicalTrials.gov registry entry for NCT02645617 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 722-participant average among 30 other Dental Caries trials with a reported enrollment target (98% lower). The listed sponsor is Advantage Dental Services, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 1 intervention - of which Varnish is the first listed.

NCT02645617 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02645617 about?

NCT02645617 is a clinical study titled "Safety Evaluation of Advantage Anti-Caries Varnish". The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.

What is the current status of trial NCT02645617?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2016-03-30. Estimated completion is 2016-10-20.

What conditions does trial NCT02645617 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT02645617?

The interventions under investigation include: Varnish (DRUG).

Who is sponsoring clinical trial NCT02645617?

This trial is sponsored by Advantage Dental Services, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02645617 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.